Company: BIAF
Filing Date: 2025-05-07
Form Type: 424B4
Source: 0001641172-25-008977
Chunk: 80

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-07
Form: 424B4
Chunk 80
---
 of May 2025 Warrants sold in this offering (including 
 the Reverse Stock Split Adjustment, but excluding the Anti-Dilution Adjustment, which remains    
 subject to Warrant Stockholder Approval); and                                                    |
| ● | 304,687                                                                                          
 shares of Common Stock issuable upon the exercise of Placement Agent Warrants issued             
 in connection with this offering.                                                                |

| 38 |

<div align='center'>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</div>

The following table sets forth information regarding the beneficial ownership of shares of the Company’s Common Stock as of May 5, 2025, by (1) each person known to the Company to beneficially own more than 5% of any class of the Company’s outstanding voting securities, (2) each director, (3) each of our named executive officers, and (4) all of the Company’s current executive officers and directors as a group.

Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power over that security, including options and warrants that are currently exercisable or will become exercisable within 60 days. In computing the number of shares beneficially owned by a person or entity and the percentage ownership of that person or entity in the table below, all shares subject to options and warrants were deemed outstanding if such securities are currently exercisable or will vest or become exercisable within 60 days of May 5, 2025. These shares were not deemed outstanding, however, for the purpose of computing the percentage ownership of any other person or entity. The percentage of beneficial ownership of the Company’s Common Stock before the offering is based on 18,246,331 shares of Common Stock outstanding as of May 5, 2025. The percentage of beneficial ownership of the Company’s Common Stock after the offering is based on 28,402,581 shares of Common Stock outstanding upon consummation of this offering, assuming the exercise of all Pre-Funded Warrants sold in this offering.

Unless otherwise indicated, the Company believes that each person named in the table below has sole voting and investment power with respect to all shares of Common Stock beneficially owned by such person.

| Name                                            
 and Address(1)                                  |     | Number          
 of Shares       
 of Common Stock |           |     | Before the Offering |       |   |     | Percent of Class |
| Directors